Listed

Beam Therapeutics Inc.

BEAMNasdaqCIK 1745999HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$490.0k, Q2 FY2026
Operating income−$126.6m, Q2 FY2026
Net income−$122.7m, Q2 FY2026
Beam Therapeutics Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m17.2Revenue, Q3 FY2023, three months to 2023-09-30$17.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-11-05, accession 0000950170-24-121104.Report this figure316Revenue, Q4 FY2023, three months to 2023-12-31$316.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-24, accession 0001193125-26-065194. Derived: 12-month figure less the 9-month figure.Report this figure7.4Revenue, Q1 FY2024, three months to 2024-03-31$7.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-06, accession 0000950170-25-063966.Report this figure11.8Revenue, Q2 FY2024, three months to 2024-06-30$11.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-05, accession 0000950170-25-102393.Report this figure14.3Revenue, Q3 FY2024, three months to 2024-09-30$14.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-04, accession 0001193125-25-263542.Report this figure30.1Revenue, Q4 FY2024, three months to 2024-12-31$30.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-24, accession 0001193125-26-065194. Derived: 12-month figure less the 9-month figure.Report this figure7.5Revenue, Q1 FY2025, three months to 2025-03-31$7.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-07, accession 0001193125-26-210338.Report this figure8.5Revenue, Q2 FY2025, three months to 2025-06-30$8.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-04, accession 0001193125-26-331541.Report this figure9.7Revenue, Q3 FY2025, three months to 2025-09-30$9.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-04, accession 0001193125-25-263542.Report this figure114Revenue, Q4 FY2025, three months to 2025-12-31$114.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-24, accession 0001193125-26-065194. Derived: 12-month figure less the 9-month figure.Report this figure31.7Revenue, Q1 FY2026, three months to 2026-03-31$31.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-07, accession 0001193125-26-210338.Report this figure0.5Revenue, Q2 FY2026, three months to 2026-06-30$490.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-04, accession 0001193125-26-331541.Report this figure
Research and development$m100Research and development, Q3 FY2023, three months to 2023-09-30$100.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-05, accession 0000950170-24-121104.Report this figure140Research and development, Q4 FY2023, three months to 2023-12-31$140.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-24, accession 0001193125-26-065194. Derived: 12-month figure less the 9-month figure.Report this figure84.8Research and development, Q1 FY2024, three months to 2024-03-31$84.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-06, accession 0000950170-25-063966.Report this figure87.0Research and development, Q2 FY2024, three months to 2024-06-30$87.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-05, accession 0000950170-25-102393.Report this figure94.3Research and development, Q3 FY2024, three months to 2024-09-30$94.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-04, accession 0001193125-25-263542.Report this figure101Research and development, Q4 FY2024, three months to 2024-12-31$101.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-24, accession 0001193125-26-065194. Derived: 12-month figure less the 9-month figure.Report this figure98.8Research and development, Q1 FY2025, three months to 2025-03-31$98.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-07, accession 0001193125-26-210338.Report this figure102Research and development, Q2 FY2025, three months to 2025-06-30$101.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-04, accession 0001193125-26-331541.Report this figure110Research and development, Q3 FY2025, three months to 2025-09-30$109.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-04, accession 0001193125-25-263542.Report this figure99.3Research and development, Q4 FY2025, three months to 2025-12-31$99.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-24, accession 0001193125-26-065194. Derived: 12-month figure less the 9-month figure.Report this figure105Research and development, Q1 FY2026, three months to 2026-03-31$104.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-07, accession 0001193125-26-210338.Report this figure95.1Research and development, Q2 FY2026, three months to 2026-06-30$95.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-04, accession 0001193125-26-331541.Report this figure
Operating income$m(108)Operating income, Q3 FY2023, three months to 2023-09-30−$108.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-05, accession 0000950170-24-121104.Report this figure133Operating income, Q4 FY2023, three months to 2023-12-31$132.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-24, accession 0001193125-26-065194. Derived: 12-month figure less the 9-month figure.Report this figure(104)Operating income, Q1 FY2024, three months to 2024-03-31−$104.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-06, accession 0000950170-25-063966.Report this figure(105)Operating income, Q2 FY2024, three months to 2024-06-30−$104.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-05, accession 0000950170-25-102393.Report this figure(107)Operating income, Q3 FY2024, three months to 2024-09-30−$106.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-04, accession 0001193125-25-263542.Report this figure(100)Operating income, Q4 FY2024, three months to 2024-12-31−$100.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-24, accession 0001193125-26-065194. Derived: 12-month figure less the 9-month figure.Report this figure(119)Operating income, Q1 FY2025, three months to 2025-03-31−$119.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001193125-26-210338.Report this figure(120)Operating income, Q2 FY2025, three months to 2025-06-30−$120.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-04, accession 0001193125-26-331541.Report this figure(127)Operating income, Q3 FY2025, three months to 2025-09-30−$126.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-04, accession 0001193125-25-263542.Report this figure(17.4)Operating income, Q4 FY2025, three months to 2025-12-31−$17.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-24, accession 0001193125-26-065194. Derived: 12-month figure less the 9-month figure.Report this figure(107)Operating income, Q1 FY2026, three months to 2026-03-31−$107.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001193125-26-210338.Report this figure(127)Operating income, Q2 FY2026, three months to 2026-06-30−$126.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-04, accession 0001193125-26-331541.Report this figure
Income tax$m0.0Income tax, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2023-11-08, accession 0000950170-23-060683.Report this figure1.4Income tax, Q4 FY2023, three months to 2023-12-31$1.4m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-24, accession 0001193125-26-065194. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-06, accession 0000950170-25-063966.Report this figure0.0Income tax, Q2 FY2024, three months to 2024-06-30$39.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-05, accession 0000950170-25-102393.Report this figure0.0Income tax, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-04, accession 0001193125-25-263542. Derived: 9-month figure less the 6-month figure.Report this figure0.0Income tax, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-24, accession 0001193125-26-065194. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-07, accession 0001193125-26-210338.Report this figure0.0Income tax, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-04, accession 0001193125-26-331541. Derived: 6-month figure less the 3-month figure.Report this figure0.0Income tax, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-04, accession 0001193125-25-263542. Derived: 9-month figure less the 6-month figure.Report this figure0.0Income tax, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-24, accession 0001193125-26-065194. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-07, accession 0001193125-26-210338.Report this figure0.0Income tax, Q2 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-04, accession 0001193125-26-331541. Derived: 6-month figure less the 3-month figure.Report this figure
Net income$m(96.1)Net income, Q3 FY2023, three months to 2023-09-30−$96.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-05, accession 0000950170-24-121104.Report this figure143Net income, Q4 FY2023, three months to 2023-12-31$142.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-24, accession 0001193125-26-065194. Derived: 12-month figure less the 9-month figure.Report this figure(98.7)Net income, Q1 FY2024, three months to 2024-03-31−$98.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-04, accession 0001193125-25-263542.Report this figure(91.1)Net income, Q2 FY2024, three months to 2024-06-30−$91.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-04, accession 0001193125-25-263542.Report this figure(96.7)Net income, Q3 FY2024, three months to 2024-09-30−$96.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-04, accession 0001193125-25-263542.Report this figure(90.4)Net income, Q4 FY2024, three months to 2024-12-31−$90.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-24, accession 0001193125-26-065194. Derived: 12-month figure less the 9-month figure.Report this figure(108)Net income, Q1 FY2025, three months to 2025-03-31−$108.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-04, accession 0001193125-26-331541.Report this figure(102)Net income, Q2 FY2025, three months to 2025-06-30−$102.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-04, accession 0001193125-26-331541.Report this figure(113)Net income, Q3 FY2025, three months to 2025-09-30−$112.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-04, accession 0001193125-25-263542.Report this figure244Net income, Q4 FY2025, three months to 2025-12-31$244.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-24, accession 0001193125-26-065194. Derived: 12-month figure less the 9-month figure.Report this figure(94.3)Net income, Q1 FY2026, three months to 2026-03-31−$94.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-04, accession 0001193125-26-331541.Report this figure(123)Net income, Q2 FY2026, three months to 2026-06-30−$122.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-04, accession 0001193125-26-331541.Report this figure
Diluted EPS$ per share(1.22)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$1.22 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-05, accession 0000950170-24-121104.Report this figurenot reported(1.21)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$1.21 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-06, accession 0000950170-25-063966.Report this figure(1.11)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$1.11 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-05, accession 0000950170-25-102393.Report this figure(1.17)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$1.17 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-04, accession 0001193125-25-263542.Report this figurenot reported(1.23)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$1.23 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-07, accession 0001193125-26-210338.Report this figure(1.00)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$1.00 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-04, accession 0001193125-26-331541.Report this figure(1.10)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$1.10 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-04, accession 0001193125-25-263542.Report this figurenot reported(0.91)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.91 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-07, accession 0001193125-26-210338.Report this figure(1.18)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$1.18 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-04, accession 0001193125-26-331541.Report this figure
Basic EPS$ per share(1.22)Basic EPS, Q3 FY2023, three months to 2023-09-30−$1.22 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-05, accession 0000950170-24-121104.Report this figurenot reported(1.21)Basic EPS, Q1 FY2024, three months to 2024-03-31−$1.21 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-06, accession 0000950170-25-063966.Report this figure(1.11)Basic EPS, Q2 FY2024, three months to 2024-06-30−$1.11 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-05, accession 0000950170-25-102393.Report this figure(1.17)Basic EPS, Q3 FY2024, three months to 2024-09-30−$1.17 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-04, accession 0001193125-25-263542.Report this figurenot reported(1.23)Basic EPS, Q1 FY2025, three months to 2025-03-31−$1.23 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-07, accession 0001193125-26-210338.Report this figure(1.00)Basic EPS, Q2 FY2025, three months to 2025-06-30−$1.00 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-04, accession 0001193125-26-331541.Report this figure(1.10)Basic EPS, Q3 FY2025, three months to 2025-09-30−$1.10 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-04, accession 0001193125-25-263542.Report this figurenot reported(0.91)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.91 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-07, accession 0001193125-26-210338.Report this figure(1.18)Basic EPS, Q2 FY2026, three months to 2026-06-30−$1.18 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-04, accession 0001193125-26-331541.Report this figure

Balance sheet

Cash and equivalents$219.8m, Q2 FY2026
Long-term debt$100.3m, Q2 FY2026
Shareholders' equity$1.07bn, Q2 FY2026
Beam Therapeutics Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m169Cash and equivalents, Q3 FY2023, at 2023-09-30$169.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-05, accession 0000950170-24-121104.Report this figure436Cash and equivalents, FY2023, at 2023-12-31$435.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-24, accession 0001193125-26-065194.Report this figure288Cash and equivalents, Q1 FY2024, at 2024-03-31$287.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-06, accession 0000950170-25-063966.Report this figure293Cash and equivalents, Q2 FY2024, at 2024-06-30$292.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-05, accession 0000950170-25-102393.Report this figure230Cash and equivalents, Q3 FY2024, at 2024-09-30$230.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-04, accession 0001193125-25-263542.Report this figure282Cash and equivalents, FY2024, at 2024-12-31$282.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-24, accession 0001193125-26-065194.Report this figure528Cash and equivalents, Q1 FY2025, at 2025-03-31$527.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-07, accession 0001193125-26-210338.Report this figure282Cash and equivalents, Q2 FY2025, at 2025-06-30$282.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-04, accession 0001193125-26-331541.Report this figure268Cash and equivalents, Q3 FY2025, at 2025-09-30$268.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-04, accession 0001193125-25-263542.Report this figure295Cash and equivalents, FY2025, at 2025-12-31$294.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-04, accession 0001193125-26-331541.Report this figure288Cash and equivalents, Q1 FY2026, at 2026-03-31$288.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-07, accession 0001193125-26-210338.Report this figure220Cash and equivalents, Q2 FY2026, at 2026-06-30$219.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-04, accession 0001193125-26-331541.Report this figure
Current assets$m1,040Current assets, Q3 FY2023, at 2023-09-30$1.04bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-08, accession 0000950170-23-060683.Report this figure1,211Current assets, FY2023, at 2023-12-31$1.21bn. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-02-25, accession 0000950170-25-026076.Report this figure1,122Current assets, Q1 FY2024, at 2024-03-31$1.12bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-07, accession 0000950170-24-053939.Report this figure1,029Current assets, Q2 FY2024, at 2024-06-30$1.03bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-06, accession 0000950170-24-091242.Report this figure946Current assets, Q3 FY2024, at 2024-09-30$945.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-05, accession 0000950170-24-121104.Report this figure878Current assets, FY2024, at 2024-12-31$878.1m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-02-24, accession 0001193125-26-065194.Report this figure1,248Current assets, Q1 FY2025, at 2025-03-31$1.25bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-06, accession 0000950170-25-063966.Report this figure1,175Current assets, Q2 FY2025, at 2025-06-30$1.18bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-05, accession 0000950170-25-102393.Report this figure1,099Current assets, Q3 FY2025, at 2025-09-30$1.10bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-04, accession 0001193125-25-263542.Report this figure1,269Current assets, FY2025, at 2025-12-31$1.27bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-04, accession 0001193125-26-331541.Report this figure1,267Current assets, Q1 FY2026, at 2026-03-31$1.27bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-07, accession 0001193125-26-210338.Report this figure1,179Current assets, Q2 FY2026, at 2026-06-30$1.18bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-04, accession 0001193125-26-331541.Report this figure
Total assets$m1,291Total assets, Q3 FY2023, at 2023-09-30$1.29bn. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-08, accession 0000950170-23-060683.Report this figure1,460Total assets, FY2023, at 2023-12-31$1.46bn. XBRL concept us-gaap:Assets. 10-K filed 2025-02-25, accession 0000950170-25-026076.Report this figure1,360Total assets, Q1 FY2024, at 2024-03-31$1.36bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-07, accession 0000950170-24-053939.Report this figure1,261Total assets, Q2 FY2024, at 2024-06-30$1.26bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-06, accession 0000950170-24-091242.Report this figure1,171Total assets, Q3 FY2024, at 2024-09-30$1.17bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-05, accession 0000950170-24-121104.Report this figure1,104Total assets, FY2024, at 2024-12-31$1.10bn. XBRL concept us-gaap:Assets. 10-K filed 2026-02-24, accession 0001193125-26-065194.Report this figure1,467Total assets, Q1 FY2025, at 2025-03-31$1.47bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-06, accession 0000950170-25-063966.Report this figure1,391Total assets, Q2 FY2025, at 2025-06-30$1.39bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-05, accession 0000950170-25-102393.Report this figure1,311Total assets, Q3 FY2025, at 2025-09-30$1.31bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-04, accession 0001193125-25-263542.Report this figure1,481Total assets, FY2025, at 2025-12-31$1.48bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-04, accession 0001193125-26-331541.Report this figure1,481Total assets, Q1 FY2026, at 2026-03-31$1.48bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-07, accession 0001193125-26-210338.Report this figure1,386Total assets, Q2 FY2026, at 2026-06-30$1.39bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-04, accession 0001193125-26-331541.Report this figure
Current liabilities$m220Current liabilities, Q3 FY2023, at 2023-09-30$220.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-08, accession 0000950170-23-060683.Report this figure206Current liabilities, FY2023, at 2023-12-31$205.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-02-25, accession 0000950170-25-026076.Report this figure187Current liabilities, Q1 FY2024, at 2024-03-31$187.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-07, accession 0000950170-24-053939.Report this figure177Current liabilities, Q2 FY2024, at 2024-06-30$177.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-06, accession 0000950170-24-091242.Report this figure166Current liabilities, Q3 FY2024, at 2024-09-30$166.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-05, accession 0000950170-24-121104.Report this figure182Current liabilities, FY2024, at 2024-12-31$182.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-02-24, accession 0001193125-26-065194.Report this figure142Current liabilities, Q1 FY2025, at 2025-03-31$141.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-06, accession 0000950170-25-063966.Report this figure174Current liabilities, Q2 FY2025, at 2025-06-30$174.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-05, accession 0000950170-25-102393.Report this figure183Current liabilities, Q3 FY2025, at 2025-09-30$182.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-04, accession 0001193125-25-263542.Report this figure96.9Current liabilities, FY2025, at 2025-12-31$96.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-04, accession 0001193125-26-331541.Report this figure74.6Current liabilities, Q1 FY2026, at 2026-03-31$74.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-07, accession 0001193125-26-210338.Report this figure80.9Current liabilities, Q2 FY2026, at 2026-06-30$80.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-04, accession 0001193125-26-331541.Report this figure
Total liabilities$m512Total liabilities, Q3 FY2023, at 2023-09-30$511.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-08, accession 0000950170-23-060683.Report this figure478Total liabilities, FY2023, at 2023-12-31$478.4m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-02-25, accession 0000950170-25-026076.Report this figure446Total liabilities, Q1 FY2024, at 2024-03-31$446.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-07, accession 0000950170-24-053939.Report this figure407Total liabilities, Q2 FY2024, at 2024-06-30$407.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-06, accession 0000950170-24-091242.Report this figure380Total liabilities, Q3 FY2024, at 2024-09-30$380.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-05, accession 0000950170-24-121104.Report this figure370Total liabilities, FY2024, at 2024-12-31$370.3m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-02-24, accession 0001193125-26-065194.Report this figure344Total liabilities, Q1 FY2025, at 2025-03-31$343.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-06, accession 0000950170-25-063966.Report this figure344Total liabilities, Q2 FY2025, at 2025-06-30$344.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-05, accession 0000950170-25-102393.Report this figure345Total liabilities, Q3 FY2025, at 2025-09-30$345.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-04, accession 0001193125-25-263542.Report this figure243Total liabilities, FY2025, at 2025-12-31$242.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-04, accession 0001193125-26-331541.Report this figure316Total liabilities, Q1 FY2026, at 2026-03-31$316.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-07, accession 0001193125-26-210338.Report this figure319Total liabilities, Q2 FY2026, at 2026-06-30$318.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-04, accession 0001193125-26-331541.Report this figure
Long-term debt$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported100Long-term debt, Q1 FY2026, at 2026-03-31$100.2m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-05-07, accession 0001193125-26-210338.Report this figure100Long-term debt, Q2 FY2026, at 2026-06-30$100.3m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-08-04, accession 0001193125-26-331541.Report this figure
Shareholders' equity$m779Shareholders' equity, Q3 FY2023, at 2023-09-30$778.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-05, accession 0000950170-24-121104.Report this figure981Shareholders' equity, FY2023, at 2023-12-31$981.3m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-02-24, accession 0001193125-26-065194.Report this figure913Shareholders' equity, Q1 FY2024, at 2024-03-31$913.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-04, accession 0001193125-25-263542.Report this figure854Shareholders' equity, Q2 FY2024, at 2024-06-30$854.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-04, accession 0001193125-25-263542.Report this figure791Shareholders' equity, Q3 FY2024, at 2024-09-30$791.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-04, accession 0001193125-25-263542.Report this figure734Shareholders' equity, FY2024, at 2024-12-31$733.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-04, accession 0001193125-26-331541.Report this figure1,129Shareholders' equity, Q1 FY2025, at 2025-03-31$1.13bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-04, accession 0001193125-26-331541.Report this figure1,053Shareholders' equity, Q2 FY2025, at 2025-06-30$1.05bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-04, accession 0001193125-26-331541.Report this figure966Shareholders' equity, Q3 FY2025, at 2025-09-30$966.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-04, accession 0001193125-25-263542.Report this figure1,238Shareholders' equity, FY2025, at 2025-12-31$1.24bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-04, accession 0001193125-26-331541.Report this figure1,164Shareholders' equity, Q1 FY2026, at 2026-03-31$1.16bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-04, accession 0001193125-26-331541.Report this figure1,067Shareholders' equity, Q2 FY2026, at 2026-06-30$1.07bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-04, accession 0001193125-26-331541.Report this figure

Cash flow

Operating cash flow−$66.1m, Q2 FY2026
Capital expenditure$2.4m, Q2 FY2026
Beam Therapeutics Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(89.8)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$89.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-05, accession 0000950170-24-121104. Derived: 9-month figure less the 6-month figure.Report this figure135Operating cash flow, Q4 FY2023, three months to 2023-12-31$135.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-24, accession 0001193125-26-065194. Derived: 12-month figure less the 9-month figure.Report this figure(99.7)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$99.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-06, accession 0000950170-25-063966.Report this figure(83.0)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$83.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-05, accession 0000950170-25-102393. Derived: 6-month figure less the 3-month figure.Report this figure(88.1)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$88.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-04, accession 0001193125-25-263542. Derived: 9-month figure less the 6-month figure.Report this figure(76.4)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$76.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-24, accession 0001193125-26-065194. Derived: 12-month figure less the 9-month figure.Report this figure(104)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$103.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-07, accession 0001193125-26-210338.Report this figure(76.5)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$76.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-04, accession 0001193125-26-331541. Derived: 6-month figure less the 3-month figure.Report this figure(81.5)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$81.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-04, accession 0001193125-25-263542. Derived: 9-month figure less the 6-month figure.Report this figure(83.3)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$83.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-24, accession 0001193125-26-065194. Derived: 12-month figure less the 9-month figure.Report this figure(129)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$128.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-07, accession 0001193125-26-210338.Report this figure(66.1)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$66.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-04, accession 0001193125-26-331541. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m7.9Capital expenditure, Q3 FY2023, three months to 2023-09-30$7.9m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-05, accession 0000950170-24-121104. Derived: 9-month figure less the 6-month figure.Report this figure3.6Capital expenditure, Q4 FY2023, three months to 2023-12-31$3.6m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-24, accession 0001193125-26-065194. Derived: 12-month figure less the 9-month figure.Report this figure2.4Capital expenditure, Q1 FY2024, three months to 2024-03-31$2.4m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-06, accession 0000950170-25-063966.Report this figure2.0Capital expenditure, Q2 FY2024, three months to 2024-06-30$2.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-05, accession 0000950170-25-102393. Derived: 6-month figure less the 3-month figure.Report this figure1.6Capital expenditure, Q3 FY2024, three months to 2024-09-30$1.6m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-04, accession 0001193125-25-263542. Derived: 9-month figure less the 6-month figure.Report this figure3.0Capital expenditure, Q4 FY2024, three months to 2024-12-31$3.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-24, accession 0001193125-26-065194. Derived: 12-month figure less the 9-month figure.Report this figure3.1Capital expenditure, Q1 FY2025, three months to 2025-03-31$3.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-07, accession 0001193125-26-210338.Report this figure3.1Capital expenditure, Q2 FY2025, three months to 2025-06-30$3.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-04, accession 0001193125-26-331541. Derived: 6-month figure less the 3-month figure.Report this figure5.0Capital expenditure, Q3 FY2025, three months to 2025-09-30$5.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-04, accession 0001193125-25-263542. Derived: 9-month figure less the 6-month figure.Report this figure3.7Capital expenditure, Q4 FY2025, three months to 2025-12-31$3.7m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-24, accession 0001193125-26-065194. Derived: 12-month figure less the 9-month figure.Report this figure2.2Capital expenditure, Q1 FY2026, three months to 2026-03-31$2.2m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-07, accession 0001193125-26-210338.Report this figure2.4Capital expenditure, Q2 FY2026, three months to 2026-06-30$2.4m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-04, accession 0001193125-26-331541. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)104.33m, Q2 FY2026
Beam Therapeutics Inc., shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares70.3Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3070,343,196 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-08, accession 0000950170-23-060683.Report this figure72.3Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3172,273,829 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-07, accession 0000950170-24-053939.Report this figure76.3Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3076,335,175 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-06, accession 0000950170-24-091242.Report this figure79.0Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3079,024,647 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-05, accession 0000950170-24-121104.Report this figure81.7Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3181,698,633 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-06, accession 0000950170-25-063966.Report this figure82.3Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3082,312,467 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-05, accession 0000950170-25-102393.Report this figure82.4Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3082,410,095 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-04, accession 0001193125-25-263542.Report this figure88.0Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3187,975,311 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-07, accession 0001193125-26-210338.Report this figure102Diluted shares (weighted), Q2 FY2025, three months to 2025-06-30101,995,184 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-04, accession 0001193125-26-331541.Report this figure103Diluted shares (weighted), Q3 FY2025, three months to 2025-09-30102,570,801 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-04, accession 0001193125-25-263542.Report this figure103Diluted shares (weighted), Q1 FY2026, three months to 2026-03-31103,262,001 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-07, accession 0001193125-26-210338.Report this figure104Diluted shares (weighted), Q2 FY2026, three months to 2026-06-30104,326,669 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-04, accession 0001193125-26-331541.Report this figure

Shares outstanding: 103.29mShares outstanding, period not labelled, at 2026-07-28103,287,665 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-04, accession 0001193125-26-331541.Report this figure at Jul 28, 2026, from the cover of the 10-Q filed Aug 4, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:47 ET. Listed shows no prices and gives no investment advice.